VIP (Vasoactive intestinal peptide)
Neuropeptide · By Preptide Pro editorial team · Last updated
VIP (Vasoactive intestinal peptide) is a neuropeptide peptide, and it is not FDA-approved. A natural neuropeptide found in the gut, brain and lungs. Studied for its effects on blood vessels, the immune system and the lungs.
Not FDA-approvedChemistry (PubChem)
| PubChem CID | 16132300 |
|---|---|
| CAS number | 40077-57-4 |
| Molecular formula | C147H237N43O43S |
| Molecular weight | 3326.8 g/mol |
| Other names | invicorp, Vip human vip, Vasoactive intestinal octacosapeptide, RLF-100, Zyesami, aviptadilum, Samiairtm, Samiviptm |
Is VIP (Vasoactive intestinal peptide) FDA-approved?
Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).
How much research is there on VIP (Vasoactive intestinal peptide)?
PubMed lists 14,367 records for “"vasoactive intestinal peptide"”, of which 161 are tagged as human clinical trials.
| Recent study | Journal | Date |
|---|---|---|
| Glycine transporter 1 inhibitor, bitopertin, changes excitatory and inhibitory network connectivity in mouse medial prefrontal cortex. | Neuropharmacology | 2026 Dec 15 |
| Hypothalamic Neurochemical and Microglial Suppression in Long-Standing Human Hibernation-Like Syndrome. | Neuropathol Appl Neurobiol | 2026 Dec |
| Goat colostrum alleviates constipation through modulation of gut microbiota, microbial metabolism, and gastrointestinal regulators: Integrated in vitro and in vivo evidence. | Food Res Int | 2026 Dec 1 |
| VIP-Mediated Syndromes: Contrasting Presentations and Multidisciplinary Management of Two Rare Neuroendocrine Tumors. | ACG Case Rep J | 2026 Nov |
| Neuropeptide signaling in perioperative neurocognitive disorders: Receptor biology, mechanistic links, and a cautious prevention framework. | Neuropeptides | 2026 Oct 31 |
Sources
This is general research information, not medical advice. Check with a clinician before using any compound.